Networking +
Policy +
Member
Career
Choose
Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis Patients
By: Colorado BioScience Association Date: 10/07/2021
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for...
Learn MoreNew fund expands its investments into the Mid-America Mountain Plains region focusing on B2B SaaS, Cleantech, and Medtech Startups
By: Colorado BioScience Association Date: 10/05/2021
Innosphere Ventures announced the launch of its second venture capital fund, Innosphere Ventures Fund II (Fund II), that focuses on leading early-stage investments for companies who are driving innova...
Learn MoreInotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
By: Colorado BioScience Association Date: 10/05/2021
Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today...
Learn MoreLive Fully, Inc awarded a $299,000 SBIR Grant to develop Breathe Away devices for Long Term Oxygen Therapy Patients so they can confidently go about their daily activities of living without worrying about running out of oxygen
By: Colorado BioScience Association Date: 09/30/2021
Live Fully, Inc., a medical device design company is focused on improving the daily lives of lung disease patients through the development of products dedicated to improving outcomes and quality of li...
Learn MoreViridian raising $85M on new shares
By: Colorado BioScience Association Date: 09/23/2021
Viridian Therapeutics Inc. (Nasdaq: VRDN) is selling 6.2 million common shares at $11 apiece and about 23,000 shares of series B preferred stock at $733.37 to raise $85 million to continue its develop...
Learn MoreClovis pays off notes, raises $40M+ in ATM offering
By: Colorado BioScience Association Date: 09/23/2021
In an effort to clean up its balance sheet, cancer-drug manufacturer Clovis Oncology Inc. (NYSE: CLVS) has paid off $64.4 million in maturing convertible senior notes due in 2021 and raised more than...
Learn MoreAccure Acne Inc.™ announces the appointment of Jeffrey O'Donnell, Sr. to the Board
By: Colorado BioScience Association Date: 09/23/2021
Accure Acne, Inc. announced today that Jeffrey O'Donnell, Sr. has joined Accure Acne's Board of Directors. Along with Chairman and Founder Christopher Carlton and Founder Ed B...
Learn MoreSen. Michael Bennet reintroduces much needed bill to fight superbugs: PASTEUR Act
By: Colorado BioScience Association Date: 09/23/2021
As the pandemic rages on, Colorado’s senator is working to prevent the next one. With all the marvels of modern medicine, could humans still die from a paper cut? For years we’ve taken the ability to...
Learn MorePegasus Announces New Location in Denver, Colorado
By: Colorado BioScience Association Date: 09/23/2021
Pegasus, a leading provider in comprehensive cleaning and decontamination services announced today that they have opened a new office in Denver, Colorado. The new location is 3190 S. Vaughn...
Learn MoreSecurisyn Medical Awarded a $1.95M SBIR Fast-Track Grant to Develop SolidAIRity Flex™ Pediatric and Neonatal Endotracheal Securement Devices for Improved Clinical Safety
By: Colorado BioScience Association Date: 09/22/2021
Securisyn Medical LLC, a provider of novel breathing and smooth tube and catheter securement products dedicated to improving patient outcomes, today announced the award of a Fast-Track Small Business...
Learn More